Related references
Note: Only part of the references are listed.Characterization of two major urinary metabolites of the PPAR delta-agonist GW1516 and implementation of the drug in routine doping controls
Mario Thevis et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2010)
Quantification of urinary AICAR concentrations as a matter of doping controls
Andreas Thomas et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2010)
Characterization of in vitro generated metabolites of the selective androgen receptor modulators S-22 and S-23 and in vivo comparison to post-administration canine urine specimens
Mario Thevis et al.
DRUG TESTING AND ANALYSIS (2010)
Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator andarine (S-4) for routine doping control purposes
Mario Thevis et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2010)
Selective androgen receptor modulators as function promoting therapies
Shalender Bhasin et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2009)
Detection of the arylpropionamide-derived selective androgen receptor modulator (SARM) S-4 (Andarine) in a black-market product
Mario Thevis et al.
DRUG TESTING AND ANALYSIS (2009)
Emerging drugs: mechanism of action, mass spectrometry and doping control analysis
Mario Thevis et al.
JOURNAL OF MASS SPECTROMETRY (2009)
Nonsteroidal Selective Androgen Receptor Modulators (SARMs): Dissociating the Anabolic and Androgenic Activities of the Androgen Receptor for Therapeutic Benefit
Michael L. Mohler et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
AMPK and PPARδ Agonists are exercise mimetics
Vihang A. Narkar et al.
CELL (2008)
Mass spectrometry of selective androgen receptor modulators
Mario Thevis et al.
JOURNAL OF MASS SPECTROMETRY (2008)
Aryl-propionamide-derived selective androgen receptor modulators: Liquid chromatography-tandem mass spectrometry characterization of the in vitro synthesized metabolites for doping control purposes
Tiia Kuuranne et al.
DRUG METABOLISM AND DISPOSITION (2008)
Role of AMP kinase and PPARδ in the regulation of lipid and glucose metabolism in human skeletal muscle
David Kitz Kraemer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Activation of PPAR-δ in isolated rat skeletal muscle switches fuel preference from glucose to fatty acids
B. Brunmair et al.
DIABETOLOGIA (2006)
In vivo metabolism and final disposition of a novel nonsteroidal androgen in rats and dogs
Minoli A. Perera et al.
DRUG METABOLISM AND DISPOSITION (2006)
Pharmacokinetics and pharmacodynamics of nonsteroidal androgen receptor ligands
Wenqing Gao et al.
PHARMACEUTICAL RESEARCH (2006)
The role of AMP-activated protein kinase in mitochondrial biogenesis
Richard M. Reznick et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
Regulation of muscle fiber type and running endurance by PPARδ
YX Wang et al.
PLOS BIOLOGY (2004)
Peroxisome-proliferator-activated receptor δ activates fat metabolism to prevent obesity
YX Wang et al.
CELL (2003)
Pharmacology, pharmacokinetics, and metabolism of acetothiolutamide, a novel nonsteroidal agonist for the androgen receptor
DH Yin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Share Paper
